Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CKD Anemia in Dialysis Participants”

49 trials

Showing 20 of 49 results

Not applicableStudy completedNCT01902628
What this trial is testing

OPTIMA: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Participants With Chronic Kidney Disease Stages 3 and 4 Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 437
Large-scale testing (Phase 3)Study completedNCT03409107
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)

Who this might be right for
Anaemia
GlaxoSmithKline 614
Large-scale testing (Phase 3)Study completedNCT02052310
What this trial is testing

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants

Who this might be right for
Anemia in Incident Dialysis Patients
Kyntra Bio 1,043
Testing effectiveness (Phase 2)UnknownNCT02403362
What this trial is testing

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT05795140
What this trial is testing

Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 125
Post-approval studies (Phase 4)Study completedNCT04059913
What this trial is testing

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease

Who this might be right for
CKD Anemia in Dialysis Participants
Kyntra Bio 318
Not applicableStudy completedNCT02567188
What this trial is testing

MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 144
Large-scale testing (Phase 3)Ended earlyNCT00462384
What this trial is testing

Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 39
Not applicableStudy completedNCT02596945
What this trial is testing

Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

Who this might be right for
Renal ImpairmentRenal Anemia of Chronic Kidney Disease
Hoffmann-La Roche 223
Testing effectiveness (Phase 2)Study completedNCT00680043
What this trial is testing

Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

Who this might be right for
AnemiaChronic Renal FailureChronic Kidney Disease
Affymax 114
Large-scale testing (Phase 3)Study completedNCT00559637
What this trial is testing

Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 184
Testing effectiveness (Phase 2)UnknownNCT02586402
What this trial is testing

Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis

Who this might be right for
Chronic Renal FailureAnemiaDialysis
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00752609
What this trial is testing

Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

Who this might be right for
Anemia
Takeda 102
Post-approval studies (Phase 4)Study completedNCT01191983
What this trial is testing

Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy

Who this might be right for
Anemia
Hoffmann-La Roche 102
Testing effectiveness (Phase 2)Ended earlyNCT03446612
What this trial is testing

Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)

Who this might be right for
Anaemia
GlaxoSmithKline 6
Not applicableStudy completedNCT01756612
What this trial is testing

Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

Who this might be right for
Renal Anemia of Chronic Kidney Disease
Hoffmann-La Roche 551
Testing effectiveness (Phase 2)Study completedNCT03799627
What this trial is testing

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

Who this might be right for
AnemiaDialysis-dependent Chronic Kidney Disease
Akebia Therapeutics 175
Testing effectiveness (Phase 2)Study completedNCT02260193
What this trial is testing

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

Who this might be right for
AnemiaEnd Stage Renal Disease
Akebia Therapeutics 94
Large-scale testing (Phase 3)Study completedNCT03400033
What this trial is testing

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)

Who this might be right for
Anaemia
GlaxoSmithKline 407
Large-scale testing (Phase 3)Study completedNCT02648347
What this trial is testing

Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease

Who this might be right for
AnemiaNon-Dialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 1,751
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation